Flegal, KM, Carroll, MD, Kuczmarski, RJ, Johnson, CL. Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord 1998, 22: 39–47.
Ogden, CL, Carroll, MD, Curtin, LR, McDowell, MA, Tabak, CJ, et al. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006, 295: 1549–1555.
Ogden, CL, Yanovski, SZ, Carroll, MD, Flegal, KM. The epidemiology of obesity. Gastroenterology 2007, 132: 2087–2102.
Ford, ES, Mokdad, AH. Epidemiology of obesity in the Western Hemisphere. J Clin Endocrinol Metab 2008, 93: S1–S8.
Ogden, CL, Carroll, MD, Flegal, KM. High body mass index for age among US children and adolescents, 2003–2006. JAMA 2008, 299: 2401–2405.
Lawrence, VJ, Kopelman, PG. Medical consequences of obesity. Clin Dermatol 2004, 22: 296–302.
Kopelman, PG. Obesity as a medical problem. Nature 2000, 404: 635–643.
Flegal, KM, Graubard, BI, Williamson, DF, Gail, MH. Cause‐specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007, 298: 2028–2037.
Kolotkin, RL, Meter, K, Williams, GR. Quality of life and obesity. Obes Rev 2001, 2: 219–229.
Muennig, P. The body politic: the relationship between stigma and obesity‐associated disease. BMC Public Health 2008, 8: 128.
Sarlio‐Lahteenkorva, S, Stunkard, A, Rissanen, A. Psychosocial factors and quality of life in obesity. Int J Obes Relat Metab Disord 1995, 19(suppl 6): S1–S5.
Finkelstein, EA, Fiebelkorn, IC, Wang, G. National medical spending attributable to overweight and obesity: how much, and who`s paying? Health Aff (Millwood) 2003. (Suppl Web Exclusives:W3: 219–226).
Sturm, R. The effects of obesity, smoking, and drinking on medical problems and costs. Health Aff (Millwood) 2002, 21: 245–253.
Thorpe, KE, Florence, CS, Howard, DH, Joski, P. The impact of obesity on rising medical spending. Health Aff (Millwood) 2004. (Suppl Web Exclusives:W4: 480–486).
Finkelstein, EA, Trogdon, JG, Brown, DS, Allaire, BT, Dellea, PS, et al. The lifetime medical cost burden of overweight and obesity: implications for obesity prevention. Obesity (Silver Spring) 2008, 16: 1843–1848.
Trogdon, JG, Finkelstein, EA, Hylands, T, Dellea, PS, Kamal‐Bahl, SJ. Indirect costs of obesity: a review of the current literature. Obes Rev 2008, 9: 489–500.
Finkelstein, EA, Trogdon, JG, Cohen, JW, Dietz, W. Annual medical spending attributable to obesity: payer‐ and service‐specific estimates. Health Aff (Millwood) 2009, W8: 22–83.
Thorleifsson, G, Walters, GB, Gudbjartsson, DF, Steinthorsdottir, V, Sulem, P, et al. Genome‐wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 2009, 41: 18–24.
Willer, CJ, Speliotes, EK, Loos, RJ, Li, S, Lindgren, CM, et al., Genetic Investigation of ANthropometric Traits Consortium. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009, 41: 25–34.
Farooqi, IS, O`Rahilly, S. Monogenic human obesity syndromes. Recent Prog Horm Res 2004, 59: 409–424.
Chung, WK, Leibel, RL. Considerations regarding the genetics of obesity. Obesity (Silver Spring) 2008, 16(suppl 3): S33–S39.
August, GP, Caprio, S, Fennoy, I, Freemark, M, Kaufman, FR, et al. Endocrine Society: prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion. J Clin Endocrinol Metab 2008, 93: 4576–4599.
Cope, MB, Allison, DB, Critical review of the World Health Organization`s (WHO). 2007 report on ‘evidence of the long‐term effects of breastfeeding: systematic reviews and meta‐analysis’ with respect to obesity. Obes Rev 2008, 9: 594–605.
Qi, L, Cho, YA. Gene‐environment interaction and obesity. Nutr Rev 2008, 66: 684–694.
Marti, A, Martinez‐Gonzalez, MA, Martinez, JA. Interaction between genes and lifestyle factors on obesity. Proc Nutr Soc 2008, 67: 1–8.
Levin, BE. Epigenetic influences on food intake and physical activity level: review of animal studies. Obesity (Silver Spring) 2008, 16(suppl 3): S51–S54.
Abizaid, A, Horvath, TL. Brain circuits regulating energy homeostasis. Regul Pept 2008, 149: 3–10.
Berthoud, HR, Morrison, C. The brain, appetite, and obesity. Annu Rev Psychol 2008, 59: 55–92.
Lenard, NR, Berthoud, HR. Central and peripheral regulation of food intake and physical activity: pathways and genes. Obesity (Silver Spring) 2008, 16(suppl 3): S11–S22.
Morrison, CD, Berthoud, HR. Neurobiology of nutrition and obesity. Nutr Rev 2007, 65: 517–534.
Crowley, VE. Overview of human obesity and central mechanisms regulating energy homeostasis. Ann Clin Biochem 2008, 45: 245–255.
Woods, SC, D`Alessio, DA. Central control of body weight and appetite. J Clin Endocrinol Metab 2008, 93(suppl 1): S37–S50.
Meister, B. Neurotransmitters in key neurons of the hypothalamus that regulate feeding behavior and body weight. Physiol Behav 2007, 92: 263–271.
Gao, Q, Horvath, TL. Neurobiology of feeding and energy expenditure. Annu Rev Neurosci 2007, 30: 367–398.
Abizaid, A, Gao, Q, Horvath, TL. Thoughts for food: brain mechanisms and peripheral energy balance. Neuron 2006, 51: 691–702.
Morton, GJ, Cummings, DE, Baskin, DG, Barsh, GS, Schwartz, MW. Central nervous system control of food intake and body weight. Nature 2006, 443: 289–295.
Schwartz, MW, Woods, SC, Porte, D Jr, Seeley, RJ, Baskin, DG. Central nervous system control of food intake. Nature 2000, 404: 661–671.
Wang, GJ, Volkow, ND, Thanos, PK, Fowler, JS. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review. J Addict Dis 2004, 23: 39–53.
Rogers, PJ, Smit, HJ. Food craving and food “addiction”: a critical review of the evidence from a biopsychosocial perspective. Pharmacol Biochem Behav 2000, 66: 3–14.
Lutter, M, Nestler, EJ. Homeostatic and hedonic signals interact in the regulation of food intake. J Nutr 2009, 139: 629–632.
Moore, RY, Bloom, FE. Central catecholamine neuron systems: anatomy and physiology of the dopamine systems. Annu Rev Neurosci 1978, 1: 129–169.
Bjorklund, A, Dunnett, SB. Dopamine neuron systems in the brain: an update. Trends Neurosci 2007, 30: 194–202.
Fibiger, HC, Phillips, AG. Mesocorticolimbic dopamine systems and reward. Ann N Y Acad Sci 1988, 537: 206–215.
Berridge, KC, Kringelbach, ML. Affective neuroscience of pleasure: reward in humans and animals. Psychopharmacology (Berl) 2008, 199: 457–480.
Meguid, MM, Fetissov, SO, Varma, M, Sato, T, Zhang, L, et al. Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition 2000, 16: 843–857.
Smith, GP, Schneider, LH. Relationships between mesolimbic dopamine function and eating behavior. Ann N Y Acad Sci 1988, 537: 254–261.
Hoebel, BG, Hernandez, L, Schwartz, DH, Mark, GP, Hunter, GA. Microdialysis studies of brain norepinephrine, serotonin, and dopamine release during ingestive behavior. Theoretical and clinical implications. Ann N Y Acad Sci 1989, 575: 171–191; discussion 192‐3.
Salamone, JD, Correa, M. Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. Behav Brain Res 2002, 137: 3–25.
Palmiter, RD. Is dopamine a physiologically relevant mediator of feeding behavior? Trends Neurosci 2007, 30: 375–381.
Volkow, ND, Wang, GJ, Fowler, JS, Telang, F. Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Philos Trans R Soc Lond B Biol Sci 2008, 363: 3191–3200.
Palmiter, RD. Dopamine signaling in the dorsal striatum is essential for motivated behaviors: lessons from dopamine‐deficient mice. Ann N Y Acad Sci 2008, 1129: 35–46.
Wellman, PJ. Modulation of eating by central catecholamine systems. Curr Drug Targets 2005, 6: 191–199.
Bouthenet, ML, Souil, E, Martres, MP, Sokoloff, P, Giros, B, Schwartz, JC. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res 1991, 564: 203–219.
Cooper, SJ, Francis, J, Barber, DJ. Selective dopamine D‐1 receptor agonists, SK%26F 38393 and CY 208–243 reduce sucrose sham‐feeding in the rat. Neuropharmacology 1993, 32: 101–102.
Fremeau, RT Jr, Duncan, GE, Fornaretto, MG, Dearry, A, Gingrich, JA, Breese, GR, Caron, MG. Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proc Natl Acad Sci U S A 1991, 88: 3772–3776.
Ramos, EJ, Meguid, MM, Campos, AC, Coelho, JC. Neuropeptide Y, alpha‐melanocyte‐stimulating hormone, and monoamines in food intake regulation. Nutrition 2005, 21: 269–279.
Hernandez, L, Hoebel, BG. Food intake and lateral hypothalamic self‐stimulation covary after medial hypothalamic lesions or ventral midbrain 6‐hydroxydopamine injections that cause obesity. Behav Neurosci 1989, 103: 412–422.
Meguid, MM, Yang, ZJ, Montante, A. Lateral hypothalamic dopaminergic neural activity in response to total parenteral nutrition. Surgery 1993, 114: 400–405; discussion 405‐6.
Meguid, MM, Yang, ZJ, Koseki, M. Eating induced rise in LHA‐dopamine correlates with meal size in normal and bulbectomized rats. Brain Res Bull 1995, 36: 487–490.
Yang, ZJ, Koseki, M, Meguid, MM, Laviano, A. Eating‐related increase of dopamine concentration in the LHA with oronasal stimulation. Am J Physiol 1996, 270: R315–R318.
Najam, N. Involvement of dopaminergic systems in the ventromedial hypothalamic hyperphagia. Brain Res Bull 1988, 21: 571–574.
Giannakopoulos, G, Galanopoulou, P, Daifotis, Z, Couvaris, C. Effects of mesulergine treatment on diet selection, brain serotonin (5‐HT) and dopamine (DA) turnover in free feeding rats. Prog Neuropsychopharmacol Biol Psychiatry 1998, 22: 803–813.
Leibowitz, SF, Rossakis, C. Pharmacological characterization of perifornical hypothalamic dopamine receptors mediating feeding inhibition in the rat. Brain Res 1979, 172: 115–130.
Leibowitz, SF, Rossakis, C. Mapping study of brain dopamine‐ and epinephrine‐sensitive sites which cause feeding suppression in the rat. Brain Res 1979, 172: 101–113.
Gilbert, DB, Cooper, SJ. Analysis of dopamine D1 and D2 receptor involvement in d‐ and l‐amphetamine‐induced anorexia in rats. Brain Res Bull 1985, 15: 385–389.
Yang, ZJ, Meguid, MM, Koseki, M, Oler, A, Chong, C, et al. Increased food intake and body weight gain after lateral hypothalamic dopaminergic cell implantation. Neuroreport 1996, 7: 449–453.
Parada, M, Hernandez, L, Schwartz, D, Hoebel, BG. Hypothalamic infusion of amphetamine increases serotonin, dopamine and norepinephrine. Physiol Behav 1988, 44: 607–610.
Baptista, T, Parada, M, Hernandez, L. Long term administration of some antipsychotic drugs increases body weight and feeding in rats. Are D2 dopamine receptors involved? Pharmacol Biochem Behav 1987, 27: 399–405.
Meguid, MM, Yang, ZJ, Laviano, A. Meal size and number: relationship to dopamine levels in the ventromedial hypothalamic nucleus. Am J Physiol 1997, 272: R1925–R1930.
Berridge, KC, Robinson, TE, Aldridge, JW. Dissecting components of reward: ‘liking’, ‘wanting’, and learning. Curr Opin Pharmacol 2009, 9: 65–73.
Ikemoto, S. Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens‐olfactory tubercle complex. Brain Res Rev 2007, 56: 27–78.
Wise, RA. Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox Res 2008, 14: 169–183.
Cannon, CM, Palmiter, RD. Reward without dopamine. J Neurosci 2003, 23: 10827–10831.
Salamone, JD, Correa, M, Mingote, SM, Weber, SM. Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. Curr Opin Pharmacol 2005, 5: 34–41.
Berridge, KC. The debate over dopamine`s role in reward: the case for incentive salience. Psychopharmacology (Berl) 2007, 191: 391–431.
Baldo, BA, Kelley, AE. Discrete neurochemical coding of distinguishable motivational processes: insights from nucleus accumbens control of feeding. Psychopharmacology (Berl) 2007, 191: 439–459.
Kelley, AE, Baldo, BA, Pratt, WE, Will, MJ. Corticostriatal‐hypothalamic circuitry and food motivation: integration of energy, action and reward. Physiol Behav 2005, 86: 773–795.
Hernandez, L, Hoebel, BG. Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis. Life Sci 1988, 42: 1705–1712.
Hoebel, BG. Brain neurotransmitters in food and drug reward. Am J Clin Nutr 1985, 42(suppl 5): 1133–1150.
Hernandez, L, Lee, F, Hoebel, BG. Simultaneous microdialysis and amphetamine infusion in the nucleus accumbens and striatum of freely moving rats: increase in extracellular dopamine and serotonin. Brain Res Bull 1987, 19: 623–628.
Liang, NC, Hajnal, A, Norgren, R. Sham feeding corn oil increases accumbens dopamine in the rat. Am J Physiol Regul Integr Comp Physiol 2006, 291: R1236–R1239.
Hajnal, A, Smith, GP, Norgren, R. Oral sucrose stimulation increases accumbens dopamine in the rat. Am J Physiol Regul Integr Comp Physiol 2004, 286: R31–R37.
Hajnal, A, Norgren, R. Accumbens dopamine mechanisms in sucrose intake. Brain Res 2001, 904: 76–84.
Salamone, JD, Cousins, MS, Snyder, BJ. Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis. Neurosci Biobehav Rev 1997, 21: 341–359.
Szczypka, MS, Rainey, MA, Kim, DS, Alaynick, WA, Marck, BT, et al. Feeding behavior in dopamine‐deficient mice. Proc Natl Acad Sci USA 1999, 96: 12138–12143.
Szczypka, MS, Kwok, K, Brot, MD, Marck, BT, Matsumoto, AM, et al. Dopamine production in the caudate putamen restores feeding in dopamine‐deficient mice. Neuron 2001, 30: 819–828.
Wang, GJ, Volkow, ND, Fowler, JS. The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin Ther Targets 2002, 6: 601–609.
Zheng, H, Berthoud, HR. Eating for pleasure or calories. Curr Opin Pharmacol 2007, 7: 607–612.
Zheng, H, Berthoud, HR. Neural systems controlling the drive to eat: mind versus metabolism. Physiology (Bethesda) 2008, 23: 75–83.
Berridge, KC, Robinson, TE. Parsing reward. Trends Neurosci 2003, 26: 507–513.
Elman, I, Borsook, D, Lukas, SE. Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with second‐generation antipsychotic agents. Neuropsychopharmacology 2006, 31: 2091–2120.
Holtzman, SG. Behavioral effects of separate and combined administration of naloxone and d‐amphetamine. J Pharmacol Exp Ther 1974, 189: 51–60.
Yeomans, MR, Gray, RW. Opioid peptides and the control of human ingestive behaviour. Neurosci Biobehav Rev 2002, 26: 713–728.
Erlanson‐Albertsson, C. How palatable food disrupts appetite regulation. Basic Clin Pharmacol Toxicol 2005, 97: 61–73.
Pecina, S. Opioid reward ‘liking’ and ‘wanting’ in the nucleus accumbens. Physiol Behav 2008, 94: 675–680.
Figlewicz, DP, Benoit, SC. Insulin, leptin, and food reward: update 2008. Am J Physiol Regul Integr Comp Physiol 2009, 296: R9–R19.
DiLeone, RJ, Georgescu, D, Nestler, EJ. Lateral hypothalamic neuropeptides in reward and drug addiction. Life Sci 2003, 73: 759–768.
Hommel, JD, Trinko, R, Sears, RM, Georgescu, D, Liu, ZW, et al. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 2006, 51: 801–810.
Figlewicz, DP, Bennett, JL, Aliakbari, S, Zavosh, A, Sipols, AJ. Insulin acts at different CNS sites to decrease acute sucrose intake and sucrose self‐administration in rats. Am J Physiol Regul Integr Comp Physiol 2008, 295: R388–R394.
Pardini, AW, Nguyen, HT, Figlewicz, DP, Baskin, DG, Williams, DL, et al. Distribution of insulin receptor substrate‐2 in brain areas involved in energy homeostasis. Brain Res 2006, 1112: 169–178.
Malik, S, McGlone, F, Bedrossian, D, Dagher, A. Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab 2008, 7: 400–409.
Abizaid, A, Liu, ZW, Andrews, ZB, Shanabrough, M, Borok, E, et al. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest 2006, 116: 3229–3239.
Bassareo, V, Di Chiara, G. Differential responsiveness of dopamine transmission to food‐stimuli in nucleus accumbens shell/core compartments. Neuroscience 1999, 89: 637–641.
Figlewicz, DP, Brot, MD, McCall, AL, Szot, P. Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study. Brain Res 1996, 736: 54–60.
Figlewicz, DP, Szot, P, Chavez, M, Woods, SC, Veith, RC. Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra. Brain Res 1994, 644: 331–334.
Figlewicz, DP. Adiposity signals and food reward: expanding the CNS roles of insulin and leptin. Am J Physiol Regul Integr Comp Physiol 2003, 284: R882–R892.
Olszewski, PK, Schioth, HB, Levine, AS. Ghrelin in the CNS: from hunger to a rewarding and memorable meal? Brain Res Rev 2008, 58: 160–170.
Jerlhag, E, Egecioglu, E, Dickson, SL, Andersson, M, Svensson, L, Engel, JA. Ghrelin stimulates locomotor activity and accumbal dopamine‐overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addict Biol 2006, 11: 45–54.
Naleid, AM, Grace, MK, Cummings, DE, Levine, AS. Ghrelin induces feeding in the mesolimbic reward pathway between the ventral tegmental area and the nucleus accumbens. Peptides 2005, 26: 2274–2279.
Quarta, D, Di Francesco, C, Melotto, S, Mangiarini, L, Heidbreder, C, et al. Systemic administration of ghrelin increases extracellular dopamine in the shell but not the core subdivision of the nucleus accumbens. Neurochem Int 2009, 54: 89–94.
Toshinai, K, Date, Y, Murakami, N, Shimada, M, Mondal, MS, et al. Ghrelin‐induced food intake is mediated via the orexin pathway. Endocrinology 2003, 144: 1506–1512.
Chen, HY, Trumbauer, ME, Chen, AS, Weingarth, DT, Adams, JR, et al. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti‐related protein. Endocrinology 2004, 145: 2607–2612.
Benoit, SC, Tracy, AL, Davis, JF, Choi, D, Clegg, DJ. Novel functions of orexigenic hypothalamic peptides: from genes to behavior. Nutrition 2008, 24: 843–847.
Harris, GC, Wimmer, M, Aston‐Jones, G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 2005, 437: 556–559.
Narita, M, Nagumo, Y, Hashimoto, S, Narita, M, Khotib, J, et al. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 2006, 26: 398–405.
Sakurai, T, Amemiya, A, Ishii, M, Matsuzaki, I, Chemelli, RM, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein‐coupled receptors that regulate feeding behavior. Cell 1998, 92: 573–585.
Borgland, SL, Taha, SA, Sarti, F, Fields, HL, Bonci, A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 2006, 49: 589–601.
Vittoz, NM, Schmeichel, B, Berridge, CW. Hypocretin /orexin preferentially activates caudomedial ventral tegmental area dopamine neurons. Eur J Neurosci 2008, 28: 1629–1640.
Alberto, CO, Trask, RB, Quinlan, ME, Hirasawa, M. Bidirectional dopaminergic modulation of excitatory synaptic transmission in orexin neurons. J Neurosci 2006, 26: 10043–10050.
Bubser, M, Fadel, JR, Jackson, LL, Meador‐Woodruff, JH, Jing, D, et al. Dopaminergic regulation of orexin neurons. Eur J Neurosci 2005, 21: 2993–3001.
Pissios, P, Bradley, RL, Maratos‐Flier, E. Expanding the scales: The multiple roles of MCH in regulating energy balance and other biological functions. Endocr Rev 2006, 27: 606–620.
Qu, D, Ludwig, DS, Gammeltoft, S, Piper, M, Pelleymounter, MA, et al. A role for melanin‐concentrating hormone in the central regulation of feeding behaviour. Nature 1996, 380: 243–247.
Georgescu, D, Sears, RM, Hommel, JD, Barrot, M, Bolanos, CA, et al. The hypothalamic neuropeptide melanin‐concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced‐swim performance. J Neurosci 2005, 25: 2933–2940.
Chung, S, Hopf, FW, Nagasaki, H, Li, CY, Belluzzi, JD, et al. The melanin‐concentrating hormone system modulates cocaine reward. Proc Natl Acad Sci U S A 2009, 106: 6772–6777.
Pissios, P, Frank, L, Kennedy, AR, Porter, DR, Marino, FE, et al. Dysregulation of the mesolimbic dopamine system and reward in MCH‐/‐ mice. Biol Psychiatry 2008, 64: 184–191.
Fetissov, SO, Byrne, LC, Hassani, H, Ernfors, P, Hokfelt, T. Characterization of neuropeptide Y Y2 and Y5 receptor expression in the mouse hypothalamus. J Comp Neurol 2004, 470: 256–265.
Korotkova, TM, Brown, RE, Sergeeva, OA, Ponomarenko, AA, Haas, HL. Effects of arousal‐ and feeding‐related neuropeptides on dopaminergic and GABAergic neurons in the ventral tegmental area of the rat. Eur J Neurosci 2006, 23: 2677–2685.
Cao, G, Gardner, A, Westfall, TC. Mechanism of dopamine mediated inhibition of neuropeptide Y release from pheochromocytoma cells (PC12 cells). Biochem Pharmacol 2007, 73: 1446–1454.
Pelletier, G, Simard, J. Dopaminergic regulation of pre‐proNPY mRNA levels in the rat arcuate nucleus. Neurosci Lett 1991, 127: 96–98.
Smialowska, M, Bajkowska, M, Heilig, M, Obuchowicz, E, Turchan, J, et al. Pharmacological studies on the monoaminergic influence on the synthesis and expression of neuropeptide Y and corticotropin releasing factor in rat brain amygdala. Neuropeptides 2001, 35: 82–91.
Lindefors, N, Brene, S, Herrera‐Marschitz, M, Persson, H. Neuropeptide gene expression in brain is differentially regulated by midbrain dopamine neurons. Exp Brain Res 1990, 80: 489–500.
Yang, SC, Shieh, KR. Differential effects of melanin concentrating hormone on the central dopaminergic neurons induced by the cocaine‐ and amphetamine‐regulated transcript peptide. J Neurochem 2005, 92: 637–646.
Lindblom, J, Opmane, B, Mutulis, F, Mutule, I, Petrovska, R, et al. The MC4 receptor mediates alpha‐MSH induced release of nucleus accumbens dopamine. Neuroreport 2001, 12: 2155–2158.
Lindblom, J, Kask, A, Hagg, E, Harmark, L, Bergstrom, L, Wikberg, J. Chronic infusion of a melanocortin receptor agonist modulates dopamine receptor binding in the rat brain. Pharmacol Res 2002, 45: 119–124.
Tiligada, E, Wilson, JF. D2‐ but not D1‐dopamine receptors are involved in the inhibitory control of alpha‐melanocyte‐stimulating hormone release from the rat hypothalamus. Exp Brain Res 1989, 74: 645–648.
Alvaro, JD, Taylor, JR, Duman, RS. Molecular and behavioral interactions between central melanocortins and cocaine. J Pharmacol Exp Ther 2003, 304: 391–399.
Nestler, EJ, Carlezon, WA Jr. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006, 59: 1151–1159.
Patterson, TA, Brot, MD, Zavosh, A, Schenk, JO, Szot, P, et al. Food deprivation decreases mRNA and activity of the rat dopamine transporter. Neuroendocrinology 1998, 68: 11–20.
Fetissov, SO, Meguid, MM, Sato, T, Zhang, LH. Expression of dopaminergic receptors in the hypothalamus of lean and obese Zucker rats and food intake. Am J Physiol Regul Integr Comp Physiol 2002, 283: R905–R910.
Figlewicz, DP, Patterson, TA, Johnson, LB, Zavosh, A, Israel, PA, Szot, P. Dopamine transporter mRNA is increased in the CNS of Zucker fatty (fa/fa) rats. Brain Res Bull 1998, 46: 199–202.
Geiger, BM, Behr, GG, Frank, LE, Caldera‐Siu, AD, Beinfeld, MC. Evidence for defective mesolimbic dopamine exocytosis in obesity‐prone rats. FASEB J 2008, 22: 2740–2746.
Meguid, MM, Fetissov, SO, Miyata, G, Torelli, GF. Feeding pattern in obese Zucker rats after dopaminergic and serotonergic LHA grafts. Neuroreport 1999, 10: 1049–1053.
Yang, ZJ, Meguid, MM. LHA dopaminergic activity in obese and lean Zucker rats. Neuroreport 1995, 6: 1191–1194.
Orosco, M, Rouch, C, Meile, MJ, Nicolaidis, S. Spontaneous feeding‐related monoamine changes in rostromedial hypothalamus of the obese Zucker rat: a microdialysis study. Physiol Behav 1995, 57: 1103–1106.
Orosco, M, Rouch, C, Nicolaidis, S. Rostromedial hypothalamic monoamine changes in response to intravenous infusions of insulin and glucose in freely feeding obese Zucker rats: a microdialysis study. Appetite 1996, 26: 1–20.
Lemierre, S, Rouch, C, Nicolaidis, S, Orosco, M. Combined effect of obesity and aging on feeding‐induced monoamine release in the rostromedial hypothalamus of the Zucker rat. Int J Obes Relat Metab Disord 1998, 22: 993–999.
Fuemmeler, BF, Agurs‐Collins, TD, McClernon, FJ, Kollins, SH, Kail, ME, et al. Genes implicated in serotonergic and dopaminergic functioning predict BMI categories. Obesity (Silver Spring) 2008, 16: 348–355.
Comings, DE, Gade, R, MacMurray, JP, Muhleman, D, Peters, WR. Genetic variants of the human obesity (OB) gene: association with body mass index in young women, psychiatric symptoms, and interaction with the dopamine D2 receptor (DRD2) gene. Mol Psychiatry 1996, 1: 325–335.
Noble, EP, Noble, RE, Ritchie, T, Syndulko, K, Bohlman, MC, et al. D2 dopamine receptor gene and obesity. Int J Eat Disord 1994, 15: 205–217.
Wu, X, Hudmon, KS, Detry, MA, Chamberlain, RM, Spitz, MR. D2 dopamine receptor gene polymorphisms among African‐Americans and Mexican‐Americans: a lung cancer case‐control study. Cancer Epidemiol Biomarkers Prev 2000, 9: 1021–1026.
Thomas, GN, Critchley, JA, Tomlinson, B, Cockram, CS, Chan, JC. Relationships between the taqI polymorphism of the dopamine D2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. Clin Endocrinol (Oxf) 2001, 55: 605–611.
Morton, LM, Wang, SS, Bergen, AW, Chatterjee, N, Kvale, P, et al. DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Pharmacogenet Genomics 2006, 16: 901–910.
Stice, E, Spoor, S, Bohon, C, Small, DM. Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 2008, 322: 449–452.
Guo, G, North, KE, Gorden‐Larsen, P, Bulik, CM, Choi, S. Body mass, DRD4, physical activity, sedentary behavior, and family socioeconomic status: the add health study. Obesity (Silver Spring) 2007, 15: 1199–1206.
Kaplan, AS, Levitan, RD, Yilmaz, Z, Davis, C, Tharmalingam, S, et al. A DRD4/BDNF gene‐gene interaction associated with maximum BMI in women with bulimia nervosa. Int J Eat Disord 2008, 41: 22–28.
Need, AC, Ahmadi, KR, Spector, TD, Goldstein, DB. Obesity is associated with genetic variants that alter dopamine availability. Ann Hum Genet 2006, 70: 293–303.
Davis, CA, Levitan, RD, Reid, C, Carter, JC, Kaplan, AS, et al. Dopamine for “wanting” and opioids for “liking”: a comparison of obese adults with and without binge eating. Obesity (Silver Spring) 2009, 17: 1220–1225.
Wang, GJ, Volkow, ND, Logan, J, Pappas, NR, Wong, CT, et al. Brain dopamine and obesity. Lancet 2001, 357: 354–357.
Wang, GJ, Volkow, ND, Telang, F, Jayne, M, Ma, J, et al. Exposure to appetitive food stimuli markedly activates the human brain. Neuroimage 2004, 21: 1790–1797.
Volkow, ND, Wang, GJ, Telang, F, Fowler, JS, Thanos, PK, et al. Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. Neuroimage 2008, 42: 1537–1543.
Volkow, ND, Wise, RA. How can drug addiction help us understand obesity? Nat Neurosci 2005, 8: 555–560.
Trinko, R, Sears, RM, Guarnieri, DJ, DiLeone, RJ. Neural mechanisms underlying obesity and drug addiction. Physiol Behav 2007, 91: 499–505.
Avena, NM, Rada, P, Hoebel, BG. Sugar and fat bingeing have notable differences in addictive‐like behavior. J Nutr 2009, 139: 623–628.
Carr, KD. Chronic food restriction: enhancing effects on drug reward and striatal cell signaling. Physiol Behav 2007, 91: 459–472.
Di Chiara, G, Bassareo, V, Fenu, S, De Luca, MA, Spina, L, et al. Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 2004, 47(suppl 1): 227–241.
Di Chiara, G, Tanda, G, Cadoni, C, Acquas, E, Bassareo, V, Carboni, E. Homologies and differences in the action of drugs of abuse and a conventional reinforcer (food) on dopamine transmission: an interpretative framework of the mechanism of drug dependence. Adv Pharmacol 1998, 42: 983–987.
Davis, JF, Tracy, AL, Schurdak, JD, Tschop, MH, Lipton, JW, et al. Exposure to elevated levels of dietary fat attenuates psychostimulant reward and mesolimbic dopamine turnover in the rat. Behav Neurosci 2008, 122: 1257–1263.
Huang, XF, Yu, Y, Zavitsanou, K, Han, M, Storlien, L. Differential expression of dopamine D2 and D4 receptor and tyrosine hydroxylase mRNA in mice prone, or resistant, to chronic high‐fat diet‐induced obesity. Brain Res Mol Brain Res 2005, 135: 150–161.
Huang, XF, Zavitsanou, K, Huang, X, Yu, Y, Wang, H, et al. Dopamine transporter and D2 receptor binding densities in mice prone or resistant to chronic high fat diet‐induced obesity. Behav Brain Res 2006, 175: 415–419.
South, T, Huang, XF. High‐fat diet exposure increases dopamine D2 receptor and decreases dopamine transporter receptor binding density in the nucleus accumbens and caudate putamen of mice. Neurochem Res 2008, 33: 598–605.
Li, Y, South, T, Han, M, Chen, J, Wang, R, et al. High‐fat diet decreases tyrosine hydroxylase mRNA expression irrespective of obesity susceptibility in mice. Brain Res 2009, 1268: 181–189.
Teegarden, SL, Nestler, EJ, Bale, TL. Delta FosB‐mediated alterations in dopamine signaling are normalized by a palatable high‐fat diet. Biol Psychiatry 2008, 64: 941–950.
Avena, NM, Hoebel, BG. A diet promoting sugar dependency causes behavioral cross‐sensitization to a low dose of amphetamine. Neuroscience 2003, 122: 17–20.
Gosnell, BA. Sucrose intake enhances behavioral sensitization produced by cocaine. Brain Res 2005, 1031: 194–201.
Avena, NM, Carrillo, CA, Needham, L, Leibowitz, SF, Hoebel, BG. Sugar‐dependent rats show enhanced intake of unsweetened ethanol. Alcohol 2004, 34: 203–209.
Muhlhausler, BS. Programming of the appetite‐regulating neural network: a link between maternal overnutrition and the programming of obesity? J Neuroendocrinol 2007, 19: 67–72.
Huang, JS, Lee, TA, Lu, MC. Prenatal programming of childhood overweight and obesity. Matern Child Health J 2007, 11: 461–473.
Junien, C, Nathanielsz, P. Report on the IASO Stock Conference 2006: early and lifelong environmental epigenomic programming of metabolic syndrome, obesity and type II diabetes. Obes Rev 2007, 8: 487–502.
Hebebrand, J, Hinney, A. Environmental and genetic risk factors in obesity. Child Adolesc Psychiatr Clin N Am 2009, 18: 83–94.
Gluckman, PD, Hanson, MA, Pinal, C. The developmental origins of adult disease. Matern Child Nutr 2005, 1: 130–141.
Michels, KB. Early life predictors of chronic disease. J Womens Health (Larchmt) 2003, 12: 157–161.
Nicolaidis, S. Prenatal imprinting of postnatal specific appetites and feeding behavior. Metabolism 2008, 57(suppl 2): S22–S26.
Djiane, J, Attig, L. Role of leptin during perinatal metabolic programming and obesity. J Physiol Pharmacol 2008, 59(suppl 1): 55–63.
Symonds, ME, Gardner, DS. Experimental evidence for early nutritional programming of later health in animals. Curr Opin Clin Nutr Metab Care 2006, 9: 278–283.
Tang, WY, Ho, SM. Epigenetic reprogramming and imprinting in origins of disease. Rev Endocr Metab Disord 2007, 8: 173–182.
Oliveira, E, Moura, EG, Santos‐Silva, AP, Fagundes, AT, Rios, AS, et al. Short‐ and long‐term effects of maternal nicotine exposure during lactation on body adiposity, lipid profile, and thyroid function of rat offspring. J Endocrinol 2009, 202: 397–405.
Fernandez‐Twinn, DS, Ozanne, SE. Mechanisms by which poor early growth programs type‐2 diabetes, obesity and the metabolic syndrome. Physiol Behav 2006, 88: 234–243.
Kirk, SL, Samuelsson, AM, Argenton, M, Dhonye, H, Kalamatianos, T, et al. Maternal obesity induced by diet in rats permanently influences central processes regulating food intake in offspring. PLoS ONE 2009, 4(N): e5870.
Tamashiro, KL, Terrillion, CE, Hyun, J, Koenig, JI, Moran, TH. Prenatal stress or high‐fat diet increases susceptibility to diet‐induced obesity in rat offspring. Diabetes 2009, 58: 1116–1125.
Nilsson, C, Larsson, BM, Jennische, E, Eriksson, E, Bjorntorp, P, et al. Maternal endotoxemia results in obesity and insulin resistance in adult male offspring. Endocrinology 2001, 142: 2622–2630.
Ptak, C, Petronis, A. Epigenetics and complex disease: from etiology to new therapeutics. Annu Rev Pharmacol Toxicol 2008, 48: 257–276.
Mehler, MF: Epigenetics and the nervous system. Ann Neurol 2008, 64: 602–617.
Jiang, Y, Langley, B, Lubin, FD, Renthal, W, Wood, MA, et al. Epigenetics in the nervous system. J Neurosci 2008, 28: 11753–11759.
Sinclair, KD, Allegrucci, C, Singh, R, Gardner, DS, Sebastian, S, et al. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc Natl Acad Sci USA 2007, 104: 19351–19356.
Bogdarina, I, Murphy, HC, Burns, SP, Clark, AJ. Investigation of the role of epigenetic modification of the rat glucokinase gene in fetal programming. Life Sci 2004, 74: 1407–1415.
Bogdarina, I, Welham, S, King, PJ, Burns, SP, Clark, AJ. Epigenetic modification of the renin‐angiotensin system in the fetal programming of hypertension. Circ Res 2007, 100: 520–526.
Stoger, R. Epigenetics and obesity. Pharmacogenomics 2008, 9: 1851–1860.
Honma, K, Mochizuki, K, Goda, T. Carbohydrate/fat ratio in the diet alters histone acetylation on the sucrase‐isomaltase gene and its expression in mouse small intestine. Biochem Biophys Res Commun 2007, 357: 1124–1129.
Simerly, RB. Hypothalamic substrates of metabolic imprinting. Physiol Behav 2008, 94: 79–89.
Mokler, DJ, Torres, OI, Galler, JR, Morgane, PJ. Stress‐induced changes in extracellular dopamine and serotonin in the medial prefrontal cortex and dorsal hippocampus of prenatally malnourished rats. Brain Res 2007, 1148: 226–233.
Valdomero, A, Isoardi, NA, Orsingher, OA, Cuadra, GR. Pharmacological reactivity to cocaine in adult rats undernourished at perinatal age: behavioral and neurochemical correlates. Neuropharmacology 2005, 48: 538–546.
Valdomero, A, Bussolino, DF, Orsingher, OA, Cuadra, GR. Perinatal protein malnutrition enhances rewarding cocaine properties in adult rats. Neuroscience 2006, 137: 221–229.
Kehoe, P, Mallinson, K, Bronzino, J, McCormick, CM. Effects of prenatal protein malnutrition and neonatal stress on CNS responsiveness. Brain Res Dev Brain Res 2001, 132: 23–31.
Naef, L, Srivastava, L, Gratton, A, Hendrickson, H, Owens, SM, et al. Maternal high fat diet during the perinatal period alters mesocorticolimbic dopamine in the adult rat offspring: reduction in the behavioral responses to repeated amphetamine administration. Psychopharmacology (Berl) 2008, 197: 83–94.
Kuperstein, F, Eilam, R, Yavin, E. Altered expression of key dopaminergic regulatory proteins in the postnatal brain following perinatal n‐3 fatty acid dietary deficiency. J Neurochem 2008, 106: 662–671.
Unger, EL, Paul, T, Murray‐Kolb, LE, Felt, B, Jones, BC, et al. Early iron deficiency alters sensorimotor development and brain monoamines in rats. J Nutr 2007, 137: 118–124.
Szczerbak, G, Nowak, P, Kostrzewa, RM, Brus, R. Maternal lead exposure produces long‐term enhancement of dopaminergic reactivity in rat offspring. Neurochem Res 2007, 32: 1791–1798.
Zhou, R, Zhang, Z, Zhu, Y, Chen, L, Sokabe, M, et al. Deficits in development of synaptic plasticity in rat dorsal striatum following prenatal and neonatal exposure to low‐dose bisphenol A. Neuroscience 2009, 159: 161–171.
Narita, M, Miyagawa, K, Mizuo, K, Yoshida, T, Suzuki, T. Changes in central dopaminergic systems and morphine reward by prenatal and neonatal exposure to bisphenol‐A in mice: evidence for the importance of exposure period. Addict Biol 2007, 12: 167–172.
Yokota, S, Mizuo, K, Moriya, N, Oshio, S, Sugawara, I, et al. Effect of prenatal exposure to diesel exhaust on dopaminergic system in mice. Neurosci Lett 2009, 449: 38–41.
Stanwood, GD, Levitt, P. Prenatal exposure to cocaine produces unique developmental and long‐term adaptive changes in dopamine D1 receptor activity and subcellular distribution. J Neurosci 2007, 27: 152–157.
Tropea, TF, Guerriero, RM, Willuhn, I, Unterwald, EM, Ehrlich, ME, et al. Augmented D1 dopamine receptor signaling and immediate‐early gene induction in adult striatum after prenatal cocaine. Biol Psychiatry 2008, 63: 1066–1074.
Strackx, E, Van den Hove, DL, Steinbusch, HP, Steinbusch, HW, Vles, JS, et al. A combined behavioral and morphological study on the effects of fetal asphyxia on the nigrostriatal dopaminergic system in adult rats. Exp Neurol 2008, 211: 413–422.
Son, GH, Chung, S, Geum, D, Kang, SS, Choi, WS, et al. Hyperactivity and alteration of the midbrain dopaminergic system in maternally stressed male mice offspring. Biochem Biophys Res Commun 2007, 352: 823–829.
Silvagni, A, Barros, VG, Mura, C, Antonelli, MC, Carboni, E. Prenatal restraint stress differentially modifies basal and stimulated dopamine and noradrenaline release in the nucleus accumbens shell: an ‘in vivo’ microdialysis study in adolescent and young adult rats. Eur J Neurosci 2008, 28: 744–758.
Kippin, TE, Szumlinski, KK, Kapasova, Z, Rezner, B, See, RE. Prenatal stress enhances responsiveness to cocaine. Neuropsychopharmacology 2008, 33: 769–782.
McArthur, S, McHale, E, Gillies, GE. The size and distribution of midbrain dopaminergic populations are permanently altered by perinatal glucocorticoid exposure in a sex‐ region‐ and time‐specific manner. Neuropsychopharmacology 2007, 32: 1462–1476.
Wang, S, Yan, JY, Lo, YK, Carvey, PM, Ling, Z. Dopaminergic and serotoninergic deficiencies in young adult rats prenatally exposed to the bacterial lipopolysaccharide. Brain Res 2009, 1265: 196–204.
Stice, E, Spoor, S, Ng, J, Zald, DH. Relation of obesity to consummatory and anticipatory food reward. Physiol Behav 2009, 97: 551–560.